GLP-1s must now include warning for potential increased risk of vision loss, FDA announces
· cbsnews.com · popularity 30/100 · 0 similar stories today · Medicine & Clinical Health (Health & Life Sciences)
Read the original at cbsnews.com →
Summary
The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.
Found in: CBS News Latest. Rating basis: single outlet; outlet tier 4; 1 feeds; feed position 13.